MME and Cachexia: It is tempting to speculate about substantial clinical relevance, as mortality and the loss in quality of life due to muscle weakness and cachexia are frequent and still coming to the fore[41] and a combination drug comprising NEP-inhibition has recently been approved, marketed and recommended by current guidelines[2,52].